Press Releases

Press Releases

Email page PDF view Print view Email Alert Social media sharing

Press Releases

Search Press Releases
  
Subscribe for Email Alerts
5/22/2017
7:05 AM ET
Press Release

PCI Biotech and RXi Pharmaceuticals Extend Research Collaboration to the Field of Immuno-oncology

5/22/2017

OSLO, Norway and MARLBOROUGH, Mass., May 22, 2017 /PRNewswire/ -- PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company, and RXi Pharmaceuticals (NASDAQ: RXII) a biotechnology company fo...

 Continue Reading
5/11/2017
7:05 AM ET
Press Release

RXi Pharmaceuticals Reports First Quarter 2017 Financial Results and Recent Corporate Highlights

5/11/2017

MARLBOROUGH, Mass., May 11, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical...

 Continue Reading
5/4/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Webcast First Quarter 2017 Financial Results on Thursday, May 11, 2017

5/4/2017

MARLBOROUGH, Mass., May 4, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical...

 Continue Reading
5/2/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2017 Annual Meeting

5/2/2017

MARLBOROUGH, Mass., May 2, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical...

 Continue Reading
5/1/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals Corporation Selected to Present at the Cavendish Global Health Impact Forum

5/1/2017

MARLBOROUGH, Mass., May 1, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical...

 Continue Reading
4/25/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present at 19th Annual TIDES: Oligonucleotide and Peptides Therapeutics Conference

4/25/2017

MARLBOROUGH, Mass., April 25, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
4/20/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals to Present an Update on its Consumer Product Development Programs at the Society for Investigative Dermatology 76th Annual Meeting

4/20/2017

MARLBOROUGH, Mass., April 20, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
4/18/2017
7:02 AM ET
Press Release

RXi Pharmaceuticals Announces New Chief Development Officer and Key Management Changes

4/18/2017

MARLBOROUGH, Mass., April 18, 2017 /PRNewswire/ -- RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medic...

 Continue Reading
Displaying 1 to 8 (of 165 releases)